国金证券：政策支持创新药械 推动脑机接口产业发展

Group 1 - The article highlights the increased support from policies for innovative medical devices and pharmaceuticals in China [1] - There will be a focus on strengthening basic hardware and software, aiming to develop high-performance products with results expected in 2027 and 2030 [1] - The brain-computer interface sector is noted for its diverse application scenarios and rich product and R&D pathways, indicating significant future potential for commercialization under supportive domestic policies [1] Group 2 - Numerous global companies are involved in product R&D, with leading domestic firms achieving multiple technological breakthroughs in the non-invasive field [1] - The products in this sector are anticipated to have substantial commercial potential [1]